ANRis, Inc.
A biotechnology company developing siRNA medicines designed to suppress disease-causing mutations while preserving normal gene function.
~¥220MFunding
ParticipantActivity from announced rounds
A biotechnology company developing siRNA medicines designed to suppress disease-causing mutations while preserving normal gene function.